Busen Wang
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
- COVID-19 Clinical Research Studies
- Viral Infections and Vectors
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- SARS-CoV-2 and COVID-19 Research 8
- Viral gastroenteritis research and epidemiology 5
- Viral Infections and Outbreaks Research 4
- COVID-19 Clinical Research Studies 2
- Genetics 8
- Virus-based gene therapy research 8
- Co-authors
- Shipo Wu (14 shared papers)Xiaohong Song (9 shared papers)Lihua Hou (13 shared papers)Wei Chen (5 shared papers)Jinlong Zhang (10 shared papers)Zhe Zhang (8 shared papers)Yu Wang (5 shared papers)Zhenghao Zhao (7 shared papers)
- Journals
- Frontiers in Immunology (4 papers)Emerging Microbes & Infections (3 papers)Frontiers in Microbiology (2 papers)Infectious Diseases and Therapy (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- ChinaCzechiaUnited States
In The Last Decade
Busen Wang
16 papers receiving 399 citations
Busen Wang's Hit Papers
Peers
Comparison fields: 5 of 68
- Infectious Diseases 256
- Molecular Medicine 44
- Health 39
- Animal Science and Zoology 37
- Endocrinology 15
Countries citing papers authored by Busen Wang
This map shows the geographic impact of Busen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Busen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Busen Wang more than expected).
Fields of papers citing papers by Busen Wang
This network shows the impact of papers produced by Busen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Busen Wang. The network helps show where Busen Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Busen Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial Hit paper breakdown → | 2021 | 192 |
| 2 | 2018 | 98 | |
| 3 | 2018 | 46 | |
| 4 | 2017 | 16 | |
| 5 | 2022 | 15 | |
| 6 | 2022 | 10 | |
| 7 | 2023 | 9 | |
| 8 | 2022 | 6 | |
| 9 | 2024 | 5 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 5 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 1 | |
| 14 | 2023 | 1 | |
| 15 | 2025 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2025 | 0 | |
| 18 | 2025 | 0 |
About Busen Wang
Busen Wang is a scholar working on Infectious Diseases, Genetics, Epidemiology, Oncology and Immunology, having authored 18 papers that have together received 414 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (8 papers), Virus-based gene therapy research (8 papers), Viral gastroenteritis research and epidemiology (5 papers), Viral Infections and Outbreaks Research (4 papers), CAR-T cell therapy research (3 papers), Animal Virus Infections Studies (2 papers), Immunotherapy and Immune Responses (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Infectious Diseases (256 citations), Molecular Medicine (44 citations), Health (39 citations), Animal Science and Zoology (37 citations) and Endocrinology (15 citations). Busen Wang has collaborated with scholars based in China, Czechia and United States. Frequent co-authors include Shipo Wu, Xiaohong Song, Lihua Hou, Wei Chen, Jinlong Zhang, Zhe Zhang, Yu Wang, Zhenghao Zhao, Qiang Guo and Jianying Huang. Their work appears in journals such as Frontiers in Immunology, Emerging Microbes & Infections, Frontiers in Microbiology, Infectious Diseases and Therapy and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.